{"name":"Alpha Fusion Inc.","slug":"alpha-fusion-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxQZzBxWFNLSTl4NmJldEpzZzdRZVY0dVRwUDlSb1Qwd3RaQXlNd0tSNWk1TWg1MmZKdk1JaXhubXNkN2xzd3UxT3FGbzFkVXVOUDJWNTNhRFBGR3dWLUQwWWxQcFY3aE9aUUhBdEZWQjhVLWZ0TUxBYlUwTVFWZzJUWE5mRngxS1l2RUpJWVhUV0hBNWtkTkdfWmlNZHFiR3NhcXB2S0ZnVzFtaTBuVUNvVVRXZkg4ekVpRWJvRmNiSmJwTldhUklQNjJmdjItNkcxeElfM3VkRFJ2ankyeVQ4ZGdRZ0NDaWRMOUtSV0RDVktkVldaUkMyOGlwd20tM1JrcW80Vzl4M1FHcDZGX2pHMHZuLTIyRVpmVWdKWGs3N2kwcHJWankzcVhyRQ?oc=5","date":"2025-10-31","type":"trial","source":"PR Newswire","summary":"Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer - PR Newswire","headline":"Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Di","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOTGlUQTBFYWpGUG05THJlaWVwazVXb1lyM19NZkhJWkZfY3RmajJZMEpwekYyZGczRTd1Z0N5M2VaVTJqaDhOWHFIVF9vWWNxN01vVndDV0hTYVR1Sl9ZS25XenJFYjhSUUluSFhmMUoxb3pSS1diWGhMSGFQZFA3NDk3eUtBTC01TVBoUzdLeDdkQnBfWXZzZkR6RzJzSGJLYVo1ZkhYd1VvWDZnSTFwRXA5b2E1QW9UeDQwc21JbjcyV3lld2RXTmVYdjBhRzB1Q1pGdTZqMWc4aGJ6LThCMEFuX0xZd0I5eXA2V0VTdW93MERyMHpSWVV3?oc=5","date":"2025-10-08","type":"pipeline","source":"PR Newswire","summary":"Alpha Fusion and Kobe City Medical Center General Hospital Establish At-211 Investigational Drug Supply System - PR Newswire","headline":"Alpha Fusion and Kobe City Medical Center General Hospital Establish At-211 Investigational Drug Supply System","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxOdnFqX2xKRmtwZ2JYRVhMS0p2ak94eW9mc2Nlb0RLZ1I2REhHeGN6akxsNVZxVG05NnZYZmJPdGQtRVNQQ3NYblFfN1VoWWpvRUxmVFZSbW1QaVBQSnZjVXRmRFEwVU84eFBEQ3Y0ZVVTWmZ0TU5VeDVMTDVCNHpIRzVnelZCLTdnbzg3b0hsRzVMeGxTd1RCXzZTZkdxRllMeWp5RERtbnRnbklwMjhqY0lfLVpQZE9odFRtek9xVVF6c3RrYkFlMFdqQ29ValFqS2xReGphM19IcjdlbWdCTjlaZG5qZUQtbUR4cUdzVnpROS1xamk0dTk2OEE2S3I5U0QzVmg5RU1HSWRfQ05SZVlzUWZ5RnBhOG1ZdkdnU1UxcW5LM2Vn?oc=5","date":"2025-06-30","type":"deal","source":"PR Newswire","summary":"Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals - PR Newswire","headline":"Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-21","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPaXBHSzU1NmttMnRhX28xWUQyNkhKcGRCMWtCTU9RVE1CdWNsVW1McWpraERocURaUVZTVlFpWVBWMC02N1BFWDd2NXdyWVZ4RkdzMGxoTkw2bGRyTVc4UURYNEI5amtnOGYzNmY0NU93T1A0RGt3TTBTRDdjVGg0WHh2c3FsalVrOUlyZUpkVzRNMXhzVkp4VmVTUWFucXpuaFpCUTdNYk5XTk1pTFpici1xSGtzeFdlUnBiRzM0c0RrWWd6bXQ4MkNEejY?oc=5","date":"2024-10-09","type":"pipeline","source":"PR Newswire","summary":"Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding - PR Newswire","headline":"Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQbWU1TnNvUDZZdGZaQ05SbXJ4ODZZVzNlUzNhVWRFdkVvQkJneGh5YnNrTTJxekRXbnRmdzJiZnJDeG9ydjZwamNtZ1ppcEpjVTEzQmwtaVhoUzJtQ2ZlcEg0TlJ4N01jaDk2ZVBkQVBJamFWNUNrMktRZGVQR2FFeTFZRGlRTWVJZ1JzQmtJdk1aMnY5WVJlbmNvcjB2TTlRR3hWUlNvVjRPZXRfQTBBRXRzSFVFVVFQYnBVaWNNUmRyQUZkQ252clFxUE16VzNXdGVZQlYyQnV2M1pXTmFKaXlNZUlldDM0Vno2TjBjb3hxb0Nq?oc=5","date":"2024-05-07","type":"earnings","source":"PR Newswire","summary":"Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates - PR Newswire","headline":"Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQTVd2a2hRRWhHU0dMNEFQMlM4TUR2Yl9LQlVEM2lvSXg5Umc1SlQ5cjNZczlKX0hHQktaLVF2eEVRbElBQUp4ZjhBWFduYnhsMjBsTXBPcUp5dG05UzR4MlJyZTBpYVkzOHViblJPVFYxNkhsSG53bDI2VEU3aXpYSTJBbkNwM0pQQlU5X1VBWER0enlFRTJlM29LUQ?oc=5","date":"2024-03-19","type":"deal","source":"AstraZeneca","summary":"AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer - AstraZeneca","headline":"AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNU0ViaXNsa3Jwa1Z3cTVvSGxab3RuSUxUb3lBbDZlLXJ2R19ZSFNTRjdZQ1dVRWxiSDM5YnBJLTFONHBBLXBRcVF5ajNkMFlTalZabUFYSzAwQlZfQkpHaGhob3kyU3k1b3NHcWtIOW1zTmlxNWF3UEJmRUZyeVpEVm43WVVHbTFHcmJETm5BeVRuNDhDZjNfMFhaSXpBRC05U0l4QmlkRm9PQXducF9MdHJtWE14cG9UWDktbVMzdU5aYkhIdThsV1o1bkJWTXdPa2RjcF81VHN3NFNxdFNpblYtUG5CSW9iTlE?oc=5","date":"2023-11-07","type":"earnings","source":"PR Newswire","summary":"Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates - PR Newswire","headline":"Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxORWJxVmlhRDF4MVktdm1RMkNGNkN4NFFGd3RETFVSM2h5UWpROF85ZlZhREplVnFGR2NYdUJfWlptV3liWjQ2Ukc0aHppQk1PSnljREk4UTRPWFlNa2FKQ0FkM0ZKNC02ZDhtQXA3bkhkYkFFREtrcG93UlJST1V4YXNfWEhsWEdDWFUyMEJuemk5MkhXQnpNWjVwcVBHMkZQbWRlTHd5dVBORlJGMk8tUm1NMEJWak1WekNYZWlwenY5WmFEOFhnU0pLbXFmUllDajB4LVhOSkxKaV9CeDlyNi0zcUJvWFQtRUoxcVQ5ZE5sT3g4ZmZjaGVIUm5rTHdmZHNmQmxQT2ppM0dCNU9MZVJUMjgtYXJU?oc=5","date":"2023-05-02","type":"pipeline","source":"PR Newswire","summary":"Fusion Pharmaceuticals Announces Opening of Radiopharmaceutical Manufacturing Facility to Produce Targeted Alpha Therapies for Cancer - PR Newswire","headline":"Fusion Pharmaceuticals Announces Opening of Radiopharmaceutical Manufacturing Facility to Produce Targeted Alpha Therapi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOUkJ6N25CNTAzUkwteTVhSnA5Z0V3emNUTV90UmE4T0N1SklKV0dnTFh6Ym1qSU1WeFJWU210OGdmUFM1My1URkdZUjNPd0gxbWRwZnlsX3ozYUZMSUxlbnYyT3FzekF5YVZ1UVhwTzdCQnU4M3ZpVGpQekJHejJzcjZtZ0NvSTdEZnp1eVJOZDlkVm1RWGtzUndsQ180RURIcnhMOEc0S1YzcnBJazAtUTd1eTRmai1HR2t0Q01mUHJjQnJORFBodW9Edm9jRlFzZUJoZmpjRllKZ2Jodm9fTlp4TnN6UEdFQmcwTXJqTXgzbkdLXzB3?oc=5","date":"2023-04-12","type":"pipeline","source":"PR Newswire","summary":"Fusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Jointly Developed Novel Targeted Alpha Therapy - PR Newswire","headline":"Fusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Jointly Developed Novel Targeted Alpha Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxQY1liWERYZllNelMwTmtKUGNTMks5dlU2LVJXVkJZaTFjNXJ1NFRzQ1JvcUVDRjVZVmttMFhtNk1DaWhVQVpMQS1VOGhmTlAySzBIbDFZUUlRMHhUOW9hMHFBM05YV0VtN0g2REpGMzBkXzZCUmp6b3pzYmM1MF9LZnY5VTNZYWRUeEZpNVB0Q1hDQWpXUXdIcVM3Q2hoOWNQc0RaX0tYUEtxZkJoQk1XcXl6S2FwLVZsTEpmMlNkS056dEh2cVBnaFBTRjNZaFFYXzZWLUlSdVBvNWFlWnd2cUVJY2hJRnUwVW9ENjdySzVTbkF0SnhQNmJQTFBhMVNQb1NtRmRHWUIxY1F4LVBrclQ2WFVxR3JzR0pmTg?oc=5","date":"2023-03-08","type":"pipeline","source":"Business Wire","summary":"Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy - Business Wire","headline":"Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9STHlOLTJ3aEpuR2VtZVhOTTZSZzB1a2ZHaXktR1V0Ni1pNjZQZUpMU2pjYVFvbFd6RGFNS1lhcUVNWVZGTVlGUTRYb1p4OVlqMTFDNkNVN2NqcnFrX0hIdnZsdmN2SzJKajBGSG9zYlVnWWZ2YkV2am9xSXNTeVE?oc=5","date":"2022-01-11","type":"trial","source":"Clinical Trials Arena","summary":"Fusion nominates first targeted alpha therapy under AstraZeneca partnership - Clinical Trials Arena","headline":"Fusion nominates first targeted alpha therapy under AstraZeneca partnership","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-05-06","type":"deal","source":"PR Newswire","summary":"Fusion Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate Fusion's Targeted Alpha Therapy (TAT) in Combination with Merck's KEYTRUDA® (pembrolizumab) in Patients With Solid Tumors","headline":"Fusion Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate Fusion's Targeted Alpha Therapy (TAT) in ","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}